Ribavirin 200 mg Oral Capsule
RxNorm 312817
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 312817 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ribavirin 200 mg Oral Capsule.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Ribavirin 200 mg Oral Capsule
(Atom ID: 12325545)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely ribavirin 200 mg/1 each conventional release oral capsule (clinical drug)
(Atom ID: 10316845)
PSNPrescribable
Prescribable Name (PSN):
Ribavirin 200 mg Oral Capsule
(Atom ID: 6371263)
PTPrescribable
Designated preferred name (PT):
Ribavirin 200 mg oral capsule
(Atom ID: 10320155)
Patient Education
Ribavirin
Ribavirin is used with an interferon medication such as peginterferon alfa-2a [Pegasys] or peginterferon alpha-2b [PEG-Intron]) to treat hepatitis C in people who have not been treated with an interferon before. Ribavirin is in a class of antiviral medications called nucleoside analogues. It works by stopping the virus that causes hepatitis C from spreading inside the body. It is not known if treatment that includes ribavirin and another medication cures hepatitis C infection, prevents liver damage that may be caused by hepatitis C, or prevents the spread of hepatitis C to other people.
[Learn More]
* Please review the disclaimer below.